• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

作者信息

Beuers Ulrich, Gershwin M Eric, Gish Robert G, Invernizzi Pietro, Jones David E J, Lindor Keith, Ma Xiong, Mackay Ian R, Parés Albert, Tanaka Atsushi, Vierling John M, Poupon Raoul

机构信息

Department of Gastroenterology & Hepatology and Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Division of Rheumatology, Allergy and Clinical Immunology, The University of California School of Medicine, Davis, CA, USA.

出版信息

Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):e57-9. doi: 10.1016/j.clinre.2015.08.001.

DOI:10.1016/j.clinre.2015.08.001
PMID:26433440
Abstract
摘要

相似文献

1
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):e57-9. doi: 10.1016/j.clinre.2015.08.001.
2
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Hepatology. 2015 Nov;62(5):1620-2. doi: 10.1002/hep.28140. Epub 2015 Sep 15.
3
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Clin Gastroenterol Hepatol. 2015 Nov;13(11):1867-9. doi: 10.1016/j.cgh.2015.08.025. Epub 2015 Sep 18.
4
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎命名的改变：从“肝硬化”到“胆管炎”
J Hepatol. 2015 Nov;63(5):1285-7. doi: 10.1016/j.jhep.2015.06.031. Epub 2015 Sep 15.
5
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Gastroenterology. 2015 Nov;149(6):1627-9. doi: 10.1053/j.gastro.2015.08.031. Epub 2015 Sep 15.
6
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Dig Liver Dis. 2015 Nov;47(11):924-6. doi: 10.1016/j.dld.2015.08.007. Epub 2015 Sep 26.
7
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Gut. 2015 Nov;64(11):1671-2. doi: 10.1136/gutjnl-2015-310593. Epub 2015 Sep 14.
8
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.原发性胆汁性胆管炎的命名变更：从“肝硬化”到“胆管炎”
Am J Gastroenterol. 2015 Nov;110(11):1536-8. doi: 10.1038/ajg.2015.312. Epub 2015 Sep 29.
9
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'.是时候将“原发性胆汁性肝硬化”改为“原发性胆汁性胆管炎”了。
Can J Gastroenterol Hepatol. 2015 Aug-Sep;29(6):293. doi: 10.1155/2015/764684. Epub 2015 Jul 21.
10
[Changing nomenclature for PBC : from 'cirrhosis' to 'cholangitis'].[原发性胆汁性胆管炎的命名变化：从“肝硬化”到“胆管炎”]
Nihon Shokakibyo Gakkai Zasshi. 2016;113(1):36-7. doi: 10.11405/nisshoshi.113.36.

引用本文的文献

1
The role of HLA-G in primary biliary cholangitis and response to therapy.HLA-G在原发性胆汁性胆管炎中的作用及对治疗的反应。
Front Immunol. 2025 Jul 29;16:1585535. doi: 10.3389/fimmu.2025.1585535. eCollection 2025.
2
Anti-RPL30 as a novel biomarker for enhanced diagnosis of autoantibody-negative primary biliary cholangitis.抗RPL30作为一种新型生物标志物用于增强自身抗体阴性原发性胆汁性胆管炎的诊断
World J Gastroenterol. 2025 May 28;31(20):104891. doi: 10.3748/wjg.v31.i20.104891.
3
A case report of primary biliary cholangitis combined with ankylosing spondylitis.
原发性胆汁性胆管炎合并强直性脊柱炎 1 例报告
Medicine (Baltimore). 2023 Oct 13;102(41):e35655. doi: 10.1097/MD.0000000000035655.
4
Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview.免疫相关胆管疾病复杂背景的若干方面——批判性综述。
Nutrients. 2023 Feb 2;15(3):760. doi: 10.3390/nu15030760.
5
Primary biliary cholangitis presenting with Fanconi syndrome: an important phenotype.原发性胆汁性胆管炎伴发 Fanconi 综合征：一种重要的表型。
BMJ Case Rep. 2022 Aug 16;15(8):e248461. doi: 10.1136/bcr-2021-248461.
6
Prevalence of Primary Biliary Cholangitis in a Cohort of Primary Sjögren's Syndrome Patients.一组原发性干燥综合征患者中原发性胆汁性胆管炎的患病率
Cureus. 2022 Apr 29;14(4):e24590. doi: 10.7759/cureus.24590. eCollection 2022 Apr.
7
Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).社论：用代谢相关脂肪性肝病（MAFLD）取代非酒精性脂肪性肝病（NAFLD）术语的国际共识建议。
Med Sci Monit. 2021 Jul 12;27:e933860. doi: 10.12659/MSM.933860.
8
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.原发性胆汁性胆管炎患者对熊去氧胆酸应答不完全的预测因素。来自肝脏疾病国家登记处的数据。
United European Gastroenterol J. 2021 Jul;9(6):699-706. doi: 10.1002/ueg2.12095. Epub 2021 Jun 8.
9
Current understanding of primary biliary cholangitis.原发性胆汁性胆管炎的现有认识。
Clin Mol Hepatol. 2021 Jan;27(1):1-21. doi: 10.3350/cmh.2020.0028. Epub 2020 Dec 3.
10
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.《IgG4 相关消化系统疾病欧洲指南——UEG 和 SGF 循证推荐》。
United European Gastroenterol J. 2020 Jul;8(6):637-666. doi: 10.1177/2050640620934911. Epub 2020 Jun 18.